Correlation Between T Rowe and Celldex Therapeutics

Can any of the company-specific risk be diversified away by investing in both T Rowe and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining T Rowe and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between T Rowe Price and Celldex Therapeutics, you can compare the effects of market volatilities on T Rowe and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in T Rowe with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of T Rowe and Celldex Therapeutics.

Diversification Opportunities for T Rowe and Celldex Therapeutics

0.29

Correlation Coefficient

T Rowe  Celldex Therapeutics

Modest diversification

The 3 months correlation between RRTLX and Celldex is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding T Rowe Price and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and T Rowe is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on T Rowe Price are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of T Rowe i.e., T Rowe and Celldex Therapeutics go up and down completely randomly.

Pair Corralation between T Rowe and Celldex Therapeutics

Assuming the 90 days horizon T Rowe Price is expected to generate 0.32 times more return on investment than Celldex Therapeutics. However, T Rowe Price is 3.11 times less risky than Celldex Therapeutics. It trades about -0.33 of its potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.16 per unit of risk. If you would invest  1,271  in T Rowe Price on September 29, 2024 and sell it today you would lose (61.00) from holding T Rowe Price or give up 4.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

T Rowe Price  vs.  Celldex Therapeutics

T Rowe Price

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days T Rowe Price has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong essential indicators, T Rowe is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Celldex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with T Rowe and Celldex Therapeutics

The main advantage of trading using opposite T Rowe and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if T Rowe position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.

The idea behind T Rowe Price and Celldex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.